ESTIMATED AGGREGATE TREATMENT BENEFIT WITH ADDITION OF MULTIPLE NOVEL MEDICATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Guardado en:
Autores principales: | Robert W. Ariss, Rajesh Gupta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/90ecf47a6c5646ad8073255d61c6e78c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021) -
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021) -
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: Charles Amir German, et al.
Publicado: (2020) -
Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
por: Jiang Li, et al.
Publicado: (2021) -
Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention
por: Ajay K. Gupta
Publicado: (2018)